Related Experiment Video
Updated: May 17, 2026
Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
Published on: February 26, 2013
Extremely high-pressure dilation with a new noncompliant balloon
José F Díaz1, Antonio Gómez-Menchero, Rosa Cardenal
1Interventional Cardiology Unit, Juan Ramon Jiménez University Hospital, 21004 Huelva, Spain. jfdiazf@yahoo.es
Insights
A new OPN NC balloon effectively treated calcified lesions in 75% of patients, offering a promising solution for challenging interventional cardiology cases with no adverse events.
Area of Science:
- Interventional Cardiology
- Cardiovascular Devices
- Medical Technology
Background:
- Calcified, nondilatable lesions pose significant challenges in interventional cardiology.
- Stent underexpansion is a primary risk factor for restenosis and thrombosis, critical complications in stenting procedures.
Observation:
- Initial experience with a novel double-layered, noncompliant OPN NC balloon was evaluated in 8 patients.
- The OPN NC balloon was utilized to address complex lesions and underexpanded stents.
Findings:
- A 75% success rate was achieved when using the OPN NC balloon at 40 atm.
- No adverse sequelae were observed in patients treated with this new device, even at high pressures.
Implications:
- The OPN NC balloon demonstrates potential as a new tool for dilating challenging lesions and underexpanded stents.
- This device may offer a safer and more effective alternative when conventional noncompliant balloons fail.
- Further investigation into the OPN NC balloon's safety and efficacy in a broader patient population is warranted.
Abstract:
Calcified nondilatable lesions remain a challenge for the interventional cardiologist, and they are becoming more frequent in the catheterization laboratory as the overall complexity of interventions increases. Stent underexpansion is the main risk factor for restenosis and thrombosis, which is the most feared complication for the interventionalist.In this report, we present our initial experience (8 patients) with a new noncompliant high-pressure balloon, the OPN NC balloon, a double-layered device. When we used this device at 40 atm, our rate of success was reasonable (75%) and our patients experienced no adverse sequelae. The OPN NC balloon appears to offer a new means of dilating lesions or underexpanded stents when other noncompliant balloons have failed. Safety seems reasonable, even at pressures as high as 40 atm.
